Name: Personalized Drug Screening for Functional Tumor Profiling (Elements in Molecular Oncology) (en Inglés)
Price: 121897.00 COP
Availability: InStock
Author: El-Khoury, Victoria ; Michel, Tatiana ; Kim, Hichul
ISBN: 9781009016933

portada Personalized Drug Screening for Functional Tumor Profiling (Elements in Molecular Oncology) (en Inglés)

Formato

Libro Físico

Autor

Victoria El-Khoury

Tatiana Michel

Hichul Kim

Editorial

Cambridge University Press

Año

2022

Idioma

Inglés

N° páginas

Encuadernación

Tapa Blanda

Dimensiones

22.9 x 15.2 x 0.2 cm

Peso

0.05 kg.

ISBN13

9781009016933

Categorías

Oncología

Personalized Drug Screening for Functional Tumor Profiling (Elements in Molecular Oncology) (en Inglés)

Victoria El-Khoury (Autor) · Tatiana Michel (Autor) · Hichul Kim (Autor) · Cambridge University Press · Tapa Blanda

Libro Físico

$ 121.897

$ 221.632

Ahorras: $ 99.734

45% descuento

Envío normal

Origen: Estados Unidos (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Miércoles 29 de Mayo y el Miércoles 12 de Junio.

Lo recibirás en cualquier lugar de Colombia entre 1 y 5 días hábiles luego del envío.

Reseña del libro "Personalized Drug Screening for Functional Tumor Profiling (Elements in Molecular Oncology) (en Inglés)"

Despite considerable advances in our understanding of the biology that underlies tumor development and progression of cancer and the rapidly evolving field of personalized medicine, cancer is still one of the deadliest diseases. Many cancer patients have benefited from the survival improvements observed with targeted therapies but only a small subset of patients receiving targeted drugs experience an objective response. Because cancer is a complex and heterogeneous disease, the search for effective cancer treatments will need to address not only patient-specific molecular defects but also aspects of the tumor microenvironment. The functional tumor profiling directly measures the cellular phenotype, in particular tumor growth, in response to drugs using patient-derived tumor models and might be the next step toward precision oncology. In this Element, the authors discuss the personalized drug screening as a novel patient stratification strategy for the determination of individualized treatment choices in oncology.